Literature DB >> 12365910

Visual outcomes following macular translocation with 360-degree peripheral retinectomy.

James C Lai1, Deborah J Lapolice, Sandra S Stinnett, Carsten H Meyer, Luz M Arieu, Melissa A Keller, Cynthia A Toth.   

Abstract

OBJECTIVE: To evaluate visual outcomes following macular translocation with 360 degrees peripheral retinectomy in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
METHODS: In a prospective study, 15 consecutive patients with large subfoveal choroidal neovascularization underwent macular translocation with 360 degrees peripheral retinectomy and silicone oil tamponade. Preoperative and postoperative photographs and fluorescein angiograms were obtained to evaluate lesion size and characteristics and translocation results. Standardized near and distance visual acuity and reading speed were measured preoperatively and 6 and 12 months postoperatively. MAIN OUTCOME MEASURES: Changes in and final levels of near and distance visual acuity and reading speed.
RESULTS: Median lesion size was 9 Macular Photocoagulation Study disc areas (range, 4-16 disc areas). In all patients, the fovea was successfully translocated off the subfoveal lesion. The median near visual acuity logMAR score (logarithm of the minimum angle of resolution) improved significantly from 0.54 units to 0.40 units (Snellen equivalent, 20/70 to 20/50; P =.02) at the 6-month follow-up and stabilized at 0.54 (12 months postoperatively; Snellen equivalent, 20/70). Seven (54%) of 13 patients and 7 (58%) of 12 patients achieved reading speeds of 70 words/min or greater at the 6-month and 12-month postoperative visits, respectively. Median preoperative distance visual acuity (20/100) was maintained at both the 6-month and 12-month examinations. No postoperative retinal detachments occurred in this series.
CONCLUSION: Macular translocation with 360 degrees peripheral retinectomy and silicone oil tamponade stabilizes and can sometimes improve near and distance visual acuity and reading speed in patients with vision loss from subfoveal neovascular age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365910     DOI: 10.1001/archopht.120.10.1317

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  22 in total

1.  Age related macular degeneration: macular relocation surgery was not taken into account.

Authors:  David Wong; David G Charteris; Lyndon da Cruz
Journal:  BMJ       Date:  2003-06-28

2.  Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy.

Authors:  Cynthia A Toth; Deborah J Lapolice; Avie D Banks; Sandra S Stinnett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-05       Impact factor: 3.117

3.  Visual function 5 years or more after macular translocation surgery for myopic choroidal neovascularisation and age-related macular degeneration.

Authors:  K Takeuchi; S Kachi; E Iwata; K Ishikawa; H Terasaki
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

4.  Which treatment is best for which AMD patient?

Authors:  P Kroll; C H Meyer
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

Review 5.  Age-related macular degeneration and recent developments: new hope for old eyes?

Authors:  Brid Morris; Fraser Imrie; Ana-Maria Armbrecht; Baljean Dhillon
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

6.  Time-dependent effects on contrast sensitivity, near and distance acuity: difference in functional parameters? (Prospective, randomized pilot trial of photodynamic therapy versus full macular translocation).

Authors:  Focke Ziemssen; Matthias Lüke; Karl U Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-12-11       Impact factor: 3.117

7.  Unfolding the Therapeutic Potential of Chemical Chaperones for Age-related Macular Degeneration.

Authors:  Theodor Sauer; Mrinali Patel; Chi-Chao Chan; Jingsheng Tuo
Journal:  Expert Rev Ophthalmol       Date:  2008-02

8.  Performing subretinal injections in rodents to deliver retinal pigment epithelium cells in suspension.

Authors:  Peter D Westenskow; Toshihide Kurihara; Stephen Bravo; Daniel Feitelberg; Zack A Sedillo; Edith Aguilar; Martin Friedlander
Journal:  J Vis Exp       Date:  2015-01-23       Impact factor: 1.355

9.  [Ocular pharmacokinetics: Topical, intravitreal, and systemic drug application].

Authors:  C H Meyer; T U Krohne
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

Review 10.  Clinical characteristics and current treatment of age-related macular degeneration.

Authors:  Yoshihiro Yonekawa; Ivana K Kim
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-03       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.